Clinical Trials in New York State

Showing 8601-8620 of 17,167 trials

Clinical Evaluation of a Daily Wear Reusable Multifocal Optical Design in a Presbyopic Population

NCT04534517

The clinical study is a bilateral, single-masked (partial), single-arm, clinical trial. A total of approximately 60 eligible subjects both near-sighted and far-sighted, will be targeted to complete the study. Subjects will be fit in the study lens for approximately 2-4 days then undergo lens optimization, if required. Subjects will then be given a new pair of lenses that will be worn for approximately 2 weeks.

Visual Acuity

Johnson & Johnson Vision Care, Inc.119 participantsStarted Aug 2020

Jacksonville, Florida, United States • Longwood, Florida, United States • Maitland, Florida, United States +8 more locations

COMPLETEDPhase 369 miles

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

NCT01945775

The purpose of this open-label, 2:1 randomized phase III trial is to compare the safety and efficacy of talazoparib (also known as BMN 673) versus protocol-specific physician's choice in patients who have locally advanced and/or metastatic breast cancer with germline BRCA mutations.

Breast NeoplasmsBRCA 1 Gene MutationBRCA 2 Gene Mutation

Pfizer431 participantsStarted Oct 2013

Flagstaff, Arizona, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +359 more locations

Clinical Evaluation of a Daily Wear Reusable Multifocal Optical Design in a Presbyopic Population

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

Find Trials by Condition in New York State

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Improving Learning in Hispanics With TBI or MS

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

Argus® II Retinal Stimulation System Feasibility Protocol

Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)

A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Cook IVC Filter Study

Clinical Study of a Diagnostic Device for NG, TV and CT in Women

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population

ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1

Early Coronary Angiography Versus Delayed Coronary Angiography

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer